{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2017"],"condition":["Metastatic colorectal cancer patients"],"disease":["Metastatic Colorectal Cancer Patients"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/20951"],"location":["Netherlands"],"study_start_month":["10"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"The use of a medical nutrition supplement in patients with metastatic colorectal cancer","description":"Interventions: The test group will be asked to take the medical nutrition supplement twice per day, during the first 3 cycles of CAPOX-B treatment. The control group receives the same medical treatment with CAPOX-B and standard of care.\nPrimary outcome(s): To explore the compliance to nutritional test product intake\nStudy Design: Randomized controlled trial, Open (masking not used), N/A , unknown, Parallel","dates":{"creation":"2017-10-15"},"accession":"20951","cross_references":{"Netherlands National Trial Register":["NL6567"]}}